In a mouse model of CCl4-induced HF, the use of beta-aminopropionitrile (BAPN, an irreversible LOX inhibitor) was able to inhibit collagen cross-linking and hepatic scar tissue structure, halt the progression of fibrosis and make it easier to reverse fibrosis (Liu et al., 2016). The gene discussed is LOX; the disease is hydrops fetalis.